{"id":"NCT03329196","sponsor":"Mitsubishi Tanabe Pharma Corporation","briefTitle":"Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan","officialTitle":"A Phase III, Open-label, Confirmatory Study of MT-6548 Compared to Darbepoetin Alfa in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-30","primaryCompletion":"2019-01-08","completion":"2019-08-09","firstPosted":"2017-11-01","resultsPosted":"2021-04-12","lastUpdate":"2023-12-28"},"enrollment":304,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia; Non-dialysis Dependent Chronic Kidney Disease"],"interventions":[{"type":"DRUG","name":"MT-6548","otherNames":["vadadustat","AKB-6548"]},{"type":"DRUG","name":"Darbepoetin alfa","otherNames":[]}],"arms":[{"label":"MT-6548","type":"EXPERIMENTAL"},{"label":"Darbepoetin alfa","type":"ACTIVE_COMPARATOR"}],"summary":"For Non-dialysis subjects with anemia associated with chronic kidney disease, demonstrate non-inferiority of MT-6548 compared to darbepoetin alfa using Hb value and evaluate long-term safety of MT-6548.\n\nFor subjects not currently receiving ESAs, evaluate Hb correction and maintenance effect of MT-6548 and for subjects currently receiving ESAs, evaluate Hb conversion and maintenance effect of MT-6548","primaryOutcome":{"measure":"Mean Hb Level of Week 20 and Week 24","timeFrame":"Up to Week 24","effectByArm":[{"arm":"MT-6548","deltaMin":11.66,"sd":null},{"arm":"Darbepoetin Alfa","deltaMin":11.93,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":15},"locations":{"siteCount":31,"countries":["Japan"]},"refs":{"pmids":["33883252","38530490","36005278"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":42,"n":151},"commonTop":["Nasopharyngitis","Diarrhoea","Constipation","Contusion","Oedema peripheral"]}}